# BPC-157

> Source: https://peptidestogo.com/peptides/bpc-157/
> Last updated November 3, 2026 · PeptidesToGo Editorial Team · Educational, not medical advice

Body Protection Compound

**Status:** Not FDA-approved · compounded · Prescription only

**How it is delivered:** Injection · Oral — daily, over four to six weeks.

BPC-157 — short for “Body Protection Compound” — is a synthetic, 15-amino-acid sequence derived from a fragment of a protein found naturally in human gastric juice. It’s best known for its work on connective tissue: tendons, ligaments, muscle, and the gastrointestinal lining.

Unlike growth-hormone-releasing peptides, BPC-157 doesn’t act on the pituitary axis. It works locally — supporting [angiogenesis](https://peptidewellnessusa.com/peptides/bpc-157/) (the formation of new blood vessels), engaging nitric-oxide pathways, and helping fibroblasts migrate into injured tissue. The practical implication: better-organized healing in places where blood supply is limited and repair is normally slow. Most of this evidence comes from preclinical and early research, with a small set of human pilots so far — the full study list lives on our [PeptideWellness deep-dive](https://peptidewellnessusa.com/peptides/bpc-157/).

> “BPC-157 is the closest thing peptide therapy has to a generalist. It doesn’t replace surgery or PT, and whether it speeds up healing in people has not yet been shown.”

Last updated November 3, 2026 · PeptidesToGo Editorial Team ·
[Educational, not medical advice](https://peptidestogo.com/legal/medical-disclaimer/)

## Who it's for (or who should avoid)

### What it's aimed at

BPC-157 protocols are most commonly prescribed for:

- **Tendon and ligament injuries** — Achilles tendinopathy, rotator cuff strains, tennis/golfer’s elbow, plantar fasciitis
- **Joint pain** — particularly osteoarthritis-related knee and shoulder pain
- **GI complaints** — gut-lining irritation, NSAID-related stomach discomfort, and IBS-type symptoms
- **Post-surgical recovery** — soft-tissue procedures where slow vascularization typically delays healing
- **Performance recovery** — athletes managing chronic overuse injuries

### Who should avoid it

- Anyone with active or recent cancer — BPC-157 is pro-angiogenic, so get an oncologist’s sign-off before starting
- Anyone pregnant, breastfeeding, or planning a pregnancy — there’s no controlled human safety data
- Anyone hoping it replaces diagnosis, surgery, or physical therapy — BPC-157 does not substitute for the underlying fix, and its effect on recovery in people is unproven

## Route, dose and course

**Used for:** Soft-tissue, joint and gut-lining repair, alongside imaging, physical therapy or a defined rehab plan

**How it’s taken:** Subcutaneous injection. Some providers write it as an oral capsule or sublingual tablet for GI use. The HHS compounding policy covers injection, oral and topical forms, not sublingual.

**Doses sellers list:** Rx Peps Direct, a telehealth service filled by a 503A pharmacy, lists 0.6 mg (600 mcg) per injection. It does not say how often. — No dose is approved for BPC-157. We searched the sellers' own pages so you don't have to; the figure is theirs, not a recommendation. Your prescriber sets the dose. Where these figures come from: Rx Peps Direct peptide list (checked Oct 16, 2026)

**Cycle:** Not published — None of the sellers we checked publishes a cycle.

**Legal status:** Not FDA-approved and not on the 503A bulks list. Since October 28, 2026, HHS has said it will not act against licensed pharmacies that compound it for a named patient as a single ingredient, by subcutaneous, intramuscular, oral or topical, under the conditions of its enforcement-discretion policy. Blends and research-use-only products are outside it.

**What it costs:** About $145 a month — From the sellers' own pages on November 4, 2026; some sell it per vial or unit instead. Each figure, with what it leaves out, is in the table under “Can I actually get it?”. A vial buys a quantity, not a month: how long it lasts depends on the dose prescribed.

BPC-157 is most commonly prescribed as a subcutaneous injection. Some providers also write it as an oral capsule or sublingual tablet for GI-specific use, since the molecule is unusually stable in gastric juice — the source it was derived from.

What sellers publish (we checked their own pages on 16 October 2026):

- **Dose:** [Rx Peps Direct](https://www.rxpepsdirect.com/peptides) lists 0.6 mg (600 mcg) per injection and does not say how often. No dose is approved for BPC-157; the figure is the seller’s, not ours
- **Cycling:** none of the sellers we checked publishes one
- **Stacking:** [Rx Peps Direct](https://www.rxpepsdirect.com/peptides) sells BPC-157 blended with TB-500, and with TB-500 and KPV, in one vial

Reconstitution typically uses bacteriostatic water at a 5:1 or 2:1 ratio depending on vial size. [See our reconstitution guide for the full math.](https://peptidestogo.com/guides/reconstitution/) Dosing is something to set with your prescriber, not a self-directed protocol.

## No measured timeline

No human trial has measured how soon BPC-157 works or how long any effect lasts, and we found no source we trust for a week-by-week picture, so we do not draw one. A [systematic review published in October 2026](https://pubmed.ncbi.nlm.nih.gov/42885452/) found three small human studies with 30 patients between them, rated the evidence very low, and concluded that BPC-157 should not be used clinically outside research trials. Agree with your prescriber what you will measure and when you will check it.

## Available · from about $145/mo

Every headline price in this market excludes something. These are normalized to a
 calendar month, cheapest first, with the exclusion spelled out — the published figure
 is the footnote under it.

| Provider | From, per month | What that figure excludes | Coverage | Their own site |
| --- | --- | --- | --- | --- |
| [Live Vital](https://peptidestogo.com/providers/live-vital/) — Physician-led, monthly pricing, Draper UT | $145 (read 2026-11-04) | The dose the figure buys, which is not published; sold as a 2-month subscription, $289 every 2 months. | All 50, stated | [Go to site ↗](https://livevital.io/) |
| [Defy Medical](https://peptidestogo.com/providers/defy-medical/) — Tampa clinic, physician-led | No price for this compound | Peptides are priced per vial rather than per month, and neither the consultation nor the lab work that has to precede it is priced anywhere on the site. | Not published | [Go to site ↗](https://www.defymedical.com/) |
| PeRx — Peptide-only telehealth, Wellness MD Group PC | No price for this compound | The only peptide figure on the site is a floor for the whole menu — treatment plans "starting at $199" — so there is no price for any individual compound. The provider review is included; there is no separate consultation fee. | All 50, stated | [Go to site ↗](https://www.perxpeptides.com/) |
| [RxPepsDirect](https://peptidestogo.com/providers/rxpepsdirect/) — Per-vial prices, 503A pharmacy in Texas | $80 per vial (read 2026-11-04) | The $39 telehealth visit, charged per order. | A named list | [Go to site ↗](https://rxpepsdirect.com/) |

### Will it work where you live?

Most sellers claim all fifty states or publish nothing about coverage; a few name
 the states they serve or the ones they exclude, and the Coverage column says which.
 Either way it is the seller's own claim, so we can't filter this list by state
 without inventing a fact. What we can tell you is which state-level rules decide
 access: telehealth rules, non-resident pharmacy licensing, and who is allowed to
 prescribe.

[What shapes access in your state →](https://peptidestogo.com/tools/state-checker/)

### Prices and providers change. We keep track.

## Questions we get about BPC-157

### Is BPC-157 FDA-approved?

No — it's not an FDA-approved drug and isn't sold at retail pharmacies. There is no approved label for it to be prescribed off; licensed clinicians prescribe it and compounding pharmacies prepare it. Its compounding status moved in 2026. The FDA removed BPC-157 from its Category 2 list in April, then proposed to its advisory committee that the peptide be left off the 503A list. On July 23 the committee voted 8–6–1 the other way, recommending it for ulcerative colitis. The FDA still has to turn that recommendation into a rule, and availability varies by pharmacy, so confirm current status with your provider.

### Is it legal?

Compounding it on a prescription is now tolerated, under conditions, though it is still on no list that authorises it. Section 503A lets a pharmacy compound only from an ingredient of an FDA-approved drug, a substance with a USP monograph or one on the FDA's 503A bulks list, and BPC-157 is none of these. On October 28, 2026, HHS said it will not take action against State-licensed pharmacies and licensed physicians that compound BPC-157 for a named patient while the FDA decides whether to list it. The conditions: BPC-157 is the only active ingredient, the route is subcutaneous, intramuscular, oral or topical, the bulk substance comes from an FDA-registered manufacturer named on a certificate of analysis, and serious side effects are reported to the FDA. HHS can withdraw the policy. A blend that mixes BPC-157 with other peptides is outside it, and buying from "research chemical" sellers without a prescription is still not a lawful supply route for human use. Since November 2, 2026, LegitScript, the certifier whose seal many telehealth sites show, no longer refuses certification to sellers whose BPC-157 meets these conditions; that seal is not FDA approval.

### Are there side effects?

In published work, reported side effects are typically mild and local: injection-site irritation, mild nausea in the first few days, occasional fatigue. Serious adverse events have been rare in the studies to date. As with any prescription, discuss your full medical history with your provider before starting.

### Can I take it with my current medications?

There is no interaction profile, because the studies that would produce one have not been run. Short-term human and animal data have not raised alarms, but long-term human safety data does not exist, and absence of reports is not the same as absence of risk. Always disclose your full medication list — including supplements — to your provider.

### How much does it cost?

In the price table on this page, the monthly figure is about $145, read on November 4, 2026. Some sellers price it per vial or unit instead, shown in the same table. Its legal footing is still moving: an FDA advisory committee voted in July 2026 to recommend it for the 503A compounding list, and the agency has not acted yet. The bill comes in three parts: the consult, the medication, and your own supplies. Get the full figure in writing before you commit to a multi-month plan, because those are normally charged in full at checkout. Insurance does not cover it.

### How is BPC-157 different from TB-500?

They work differently: BPC-157 promotes new blood-vessel growth through nitric oxide, and TB-500 is a fragment of thymosin beta-4 that helps cells migrate to an injury. Neither is FDA-approved. BPC-157 has a small amount of human research; for the TB-500 fragment itself there is almost none, and most of the data belongs to its parent protein. Taking them together rests on theory, not trials. An FDA advisory committee recommended both for the compounding list in July 2026, and the FDA has not acted. HHS's October 2026 policy tolerates compounding each one on its own; a premixed BPC-157/TB-500 vial is outside it.

We publish no medical reviewer by design. Every claim on this page traces to a
 source we hold on file, and the reviewed write-up with those citations lives on our
 hub.
[Read the full research on PeptideWellness ↗](https://peptidewellnessusa.com/peptides/bpc-157/)

## Commonly stacked with

## Related peptides